Welcome to the PRESTIGE-AF project. PRESTIGE-AF is a 6,9 million euro project to optimise stroke prevention in patients with intracerebral haemorrhage. Read More

Participant recruitment to PRESTIGE-AF clinical trials

Updated: 31.07.2020

PRESTIGE-AF Study: 17 Participants
Predictive Modelling of Risk Substudy:  7 Participants
Pharmacology Substudy: 1 Participant
Longitudinal Neuroimaging Substudy: 1 Participant

Sites with recruitment: 10

Imperial College Healthcare NHS Trust – UK: 5 Participants
Northumbria Healthcare NHS Foundation Trust – UK: 2 Participants
Hull and East Yorkshire NHS Trust – UK: 1 Participant
Mid Yorkshire Hospitals NHS Trust – UK: 1 Participant
Hospital Dr Josep Trueta, Girona – Spain: 3 Participants
Essen – Germany: 1 Participant
Altenburg – Germany: 1 Participant
Tübingen – Germany: 1 Participant
Graz – Austria: 1 Participant
411 Germans Trias I Pujol Hospital Barcelona – Spain: 1 Participant

For more information about PRESTIGE-AF clinical trials and patient eligibility, contact us.

LATEST NEWS

LATEST TWEET

31 July 2020 - PRESTIGE-AF clinical trial recruitment update: - Main Study: 17 - Predictive Modelling of Risk Subst… https://t.co/5JEdJqnXoM

03:38 AM Jul 31

Our Partners

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 754517